Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAbivax Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.80 | -$0.23 | -$0.52 |
| Q2 2026 | 2 | -$0.82 | -$0.75 | -$0.79 |
| Q3 2026 | 1 | -$1.34 | -$0.22 | -$0.79 |
| Q4 2026 | 1 | -$1.35 | -$0.23 | -$0.79 |
| Q1 2027 | 1 | -$1.97 | -$0.33 | -$1.15 |
| Q2 2027 | 1 | -$2.10 | -$0.35 | -$1.23 |
| Q3 2027 | 1 | -$1.99 | -$0.33 | -$1.16 |
| Q4 2027 | 1 | -$2.02 | -$0.34 | -$1.19 |
| Q1 2028 | 1 | -$2.63 | -$0.44 | -$1.54 |
| Q2 2028 | 1 | -$2.58 | -$0.43 | -$1.51 |
| Q3 2028 | 1 | -$2.54 | -$0.43 | -$1.49 |
| Q4 2028 | 1 | -$2.62 | -$0.44 | -$1.53 |
| Q1 2029 | 1 | -$2.55 | -$0.43 | -$1.50 |
| Q2 2029 | 1 | -$2.49 | -$0.42 | -$1.46 |
| Q3 2029 | 1 | -$2.40 | -$0.40 | -$1.40 |
| Q4 2029 | 1 | -$2.39 | -$0.40 | -$1.40 |
Abivax Earnings Date And Information
Abivax last posted its earnings results on Monday, March 23rd, 2026. The company reported $-1.20411 earnings per share for the quarter, topping analysts' consensus estimates of $-1.35296 by $0.14885. The company had revenue of -2,017,000 for the quarter and had revenue of 0 for the year. Abivax has generated $-5 earnings per share over the last year ($-4.65 diluted earnings per share) and currently has a price-to-earnings ratio of -21.82. Abivax has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Abivax Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/23/2026 | Q4 2025 | -$1.35 | -$3.06 | -1.71 | $1.53 M | $-2,017,000 |
| 09/08/2025 | Q2 2025 | -$0.90 | -$1.59 | -0.69 | $1.18 M | $2.02 M |
| 03/24/2025 | Q4 2024 | -$0.68 | -$1.50 | -0.82 | $2.73 M | $7.40 M |
| 06/30/2024 | Q2 2024 | N/A | -$0.65 | N/A | $2.30 M | $3.39 M |
| 12/29/2023 | Q4 2023 | N/A | -$1.98 | N/A | N/A | $2.33 M |
| 06/29/2023 | Q2 2023 | N/A | -$1.45 | N/A | N/A | $2.25 M |
| 12/30/2022 | Q4 2022 | N/A | -$1.81 | N/A | N/A | $2.25 M |
| 06/29/2022 | Q2 2022 | N/A | -$1.76 | N/A | N/A | $2.23 M |
| 12/30/2021 | Q4 2021 | N/A | -$1.48 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$1.13 | N/A | N/A | $0 |
| 12/30/2020 | Q4 2020 | N/A | -$1.55 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$1.26 | N/A | N/A | $0 |
| 12/30/2019 | Q4 2019 | N/A | -$1.35 | N/A | N/A | $0 |
| 06/29/2019 | Q2 2019 | N/A | -$1.38 | N/A | N/A | $0 |
| 12/31/2018 | Q4 2018 | N/A | -$0.82 | N/A | N/A | $323.00 K |
| 06/30/2018 | Q2 2018 | N/A | -$0.73 | N/A | N/A | $492.00 K |
| 12/31/2017 | Q4 2017 | N/A | -$0.56 | N/A | N/A | $352.00 K |
| 06/30/2017 | Q2 2017 | N/A | -$0.57 | N/A | N/A | $4.00 K |
| 12/31/2016 | Q4 2016 | N/A | -$0.61 | N/A | N/A | $14.00 K |
| 06/30/2016 | Q2 2016 | N/A | -$0.86 | N/A | N/A | $137.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Abivax Earnings: FAQ's
In the previous quarter, Abivax (:ABVX) reported $-1.20411 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.35296 by $0.14885.
The conference call for Abivax's latest earnings report can be listened to online.
The conference call transcript for Abivax's latest earnings report can be read online.
Abivax (:ABVX) has a recorded net income of $-322,836,959.Abivax has generated $-4.65 earnings per share over the last four quarters.
Abivax (:ABVX) has a price-to-earnings ratio of -21.82 and price/earnings-to-growth ratio is 0.39.